US-based Moxe Health has secured $25m in growth capital from Trinity Capital to continue scaling its operations.
Moxe leverages technology to facilitate the exchange of clinical data between payer and provider organisations.
Go deeper with GlobalData
The company’s solutions are designed to improve efficiency and collaboration in healthcare by providing high-quality, precise data through APIs that are compatible with leading Electronic Health Records (EHRs).
Moxe Health CEO and founder Dan Wilson said: “Moxe appreciates Trinity’s support and partnership as we further advance clinical data exchange to drive affordable healthcare.
“We’re excited to scale and innovate, further enhancing our Release of Information and Point of Care Insights solutions to improve healthcare operations and deliver financial and clinical outcomes for our customers.”
See Also:
Focusing on secure, efficient, and cost-effective data exchange, Moxe executes various collaborations within the healthcare ecosystem.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe company has a significant footprint in the US healthcare system, working with prominent health systems and the largest national health plans.
By integrating seamlessly with leading EHRs, Moxe simplifies the way data is shared, enhancing operational efficiency and patient care.
Trinity Capital Life Sciences managing director Lauren Cosentino said: “Moxe’s innovative technology has the potential to revolutionize the way data is exchanged by the healthcare system.
“We look forward to partnering with Moxe’s leadership team and supporting the company’s continued growth.”
In June 2022, Moxe raised $30m in a Series B funding round. The round was led by Piper Sandler Merchant Banking and Vensana Capital, with continued support from existing investors.
The funds were allocated for team expansion and technological advancements to further refine Moxe’s clinical data exchange solutions.
The Series B funding round also marked a strategic expansion of Moxe’s leadership, with Tom Schnettler and Kirk Nielsen joining the company’s board of directors.
